SAKK auf dem European Society for Medical Oncology (ESMO) Congress
- Metaxas I. et al. SAKK 17/16: Lurbinectedin as second or third line palliative chemotherapy in malignant pleural mesothelioma (MPM): A multi-center, single-arm Phase II trial.
Session name: Proffered Paper session
Date: 30.09.2019
Lecture Time: 11:06 - 11:18
Location: Pamplona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Weitere Informationen finden Sie auf der ESMO-Website.
ESMO oral presentation SAKK 17/16
- Digklia A. et al. SAKK 57/16: NAPAGE: NAb-PAclitaxel and GEmcitabine in advanced soft tissue sarcoma. A multicenter open-label single arm phase Ib/IIa trial
Session name: Poster Display Session
Date: 28.09.2019
Lecture Time: 12:20
Location: Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Weitere Informationen finden Sie auf der ESMO website.
ESMO poster SAKK 57/16
- Mark M. et al. SAKK 95/16: Patterns of care for patients with metastatic bone disease in solid tumors – a cross sectional survey study
Session name: Poster Display session
Date: 28.09.2019
Lecture Time: 12:20
Location: Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Weitere Informationen finden Sie auf der ESMO website.
ESMO poster SAKK 95/16
11. Oktober 2019